The estimated Net Worth of Dan Puckett is at least 16 百万$ dollars as of 5 February 2024. Mr. Puckett owns over 3,229 units of Shockwave Medical stock worth over 7,031,424$ and over the last 6 years he sold SWAV stock worth over 7,698,626$. In addition, he makes 1,238,620$ as Chief Financial Officer at Shockwave Medical.
Daniel has made over 43 trades of the Shockwave Medical stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,229 units of SWAV stock worth 746,383$ on 5 February 2024.
The largest trade he's ever made was exercising 75,000 units of Shockwave Medical stock on 9 September 2019 worth over 181,500$. On average, Daniel trades about 4,611 units every 29 days since 2019. As of 5 February 2024 he still owns at least 21,005 units of Shockwave Medical stock.
You can see the complete history of Mr. Puckett stock trades at the bottom of the page.
Dan Puckett serves as Chief Financial Officer of the Company. Prior to Shockwave Medical, Prior to joining ShockWave Medical, from June 2015 to April 2016, Mr. Puckett served as Chief Financial Officer for Counsyl, a venture backed DNA testing and genetic counseling company. From 2011 to June 2015, Mr. Puckett served as Chief Financial Officer for Ariosa Diagnostics, Inc. (“Ariosa”), a molecular diagnostics company, until June 2015. Ariosa was acquired by Roche in January 2015. Mr. Puckett came to Ariosa from Forest Laboratories, Inc. in September 2011, where he served as Executive Director, Operations of Cerexa, Inc., a Forest Laboratories, Inc. subsidiary. Prior to Cerexa, Inc., Mr. Puckett held senior finance and operations positions at Affymetrix, Inc. and AOL.
As the Chief Financial Officer of Shockwave Medical, the total compensation of Daniel Puckett at Shockwave Medical is 1,238,620$. There are 1 executives at Shockwave Medical getting paid more, with Douglas Godshall having the highest compensation of 2,208,320$.
Daniel Puckett is 56, he's been the Chief Financial Officer of Shockwave Medical since 2016. There are 5 older and 9 younger executives at Shockwave Medical. The oldest executive at Shockwave Medical Inc. is John M. Adams, 74, who is the Co-Founder and Technical Advisor.
Dan's mailing address filed with the SEC is C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA, CA, 95054.
Over the last 6 years, insiders at Shockwave Medical have traded over 488,603,927$ worth of Shockwave Medical stock and bought 30,000 units worth 510,000$ . The most active insiders traders include James E Deerfield Mgmt L.P....、Antoine Papiernik、Capital Vii Fcpr Sofinnova. On average, Shockwave Medical executives and independent directors trade stock every 8 days with the average trade being worth of 10,693,924$. The most recent stock trade was executed by Trinh Phung on 17 May 2024, trading 19,763 units of SWAV stock currently worth 121,740$.
shockwave medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. inspired by 30-years of safety and efficacy in kidney stone treatment, our lithoplasty® family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. lithoplasty devices use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. an integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. in peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, lithoplasty technology demonstrated safety and consistent procedure success with low procedural complications. the technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatmen
Shockwave Medical executives and other stock owners filed with the SEC include: